Our

financial calendar

For a clear insight into our plans for the financial year ahead, we’ve created a financial calendar that provides you with an overview of important dates and events.

Communications dates

Investor conferences and roadshows

Communications dates

  • 08 May 2025

    Annual General Meeting (AGM)
    Zurich Marriott Hotel

  • 05 Aug - 18 Aug 2025

    Quiet Period

  • 19 Aug 2025

    Half-Year Results 2025
    Conference call at 11:00 am CET for analysts and media (English)

  • 02 Oct - 15 Oct 2025

    Quiet Period

  • 16 Oct 2025

    Trading Update Q3/2025
    Press Release

  • 06 Jan - 19 Jan 2026

    Quiet Period

  • 20 Jan 2026

    Revenue 2025

    Press release

  • 05 Mar - 18 Mar 2026

    Quiet Period

  • 19 Mar 2026

    Full-Year Results 2025 and Outlook 2026
    Conference call for analysts and media (English)

  • 02 Apr - 15 Apr 2026

    Quiet Period

  • 16 Apr 2026

    Trading Update Q1/2026

    Press Release

  • 12 May 2026

    Annual General Meeting (AGM)

    Zurich Marriott Hotel

  • 05 Aug - 18 Aug 2026

    Quiet Period

  • 29 Aug 2026

    Half-Year Results 2026

    Conference call for analysts and media (English)

  • 01 Oct - 14 Oct 2026

    Quiet Period

  • 15 Oct 2026

    Trading Update Q3/2026
    Press Release

Investor conferences and roadshows

  • 17 Apr 2025

    Q1 2025 Trading Update Roadshow

    Frankfurt, DE

    Meet: CEO, CFO & Investor Relations

  • 15 May 2025

    UBS - Pan European Small and Mid-Cap Conference

    London, UK

    Meet: Investor Relations

  • 12 Jun 2025

    Commerzbank and ODDO BHF - Swiss Equities Conference

    Interlaken, CH

    Meet: CFO & Investor Relations

  • 18 Sep 2025

    Investora

    Zurich, CH

    Meet: CFO & Investor Relations

  • 24 Sep 2025

    Baader - Investment Conference

    Munich, DE

    Meet: CEO & Investor Relations

  • 03 Dec 2025

    Berenberg - European Conference

    London, UK

    Meet: CEO & Investor Relations

Questions?

Want to know more? Our Investor Relations team will be glad to answer any questions you may have about the DocMorris share and related capital market topics.

Additional contacts can be found here:

Dr. Daniel Grigat
Head of Investor Relations & Sustainability